切换至 "中华医学电子期刊资源库"

中华损伤与修复杂志(电子版) ›› 2016, Vol. 11 ›› Issue (06) : 469 -472. doi: 10.3877/cma.j.issn.1673-9450.2016.06.016

所属专题: 文献

综述

老年骨质疏松机制及股骨转子间骨折治疗的研究进展
才林1,(), 艾光禹1, 孙强1   
  1. 1. 833600 克拉玛依市,新疆维吾尔自治区独山子石化医院外二科
  • 收稿日期:2016-08-26 出版日期:2016-12-01
  • 通信作者: 才林

Research progress of the mechanism of senile osteoporosis and the teatment of intertrochanteric fracture

Lin Cai1,(), Guangyu Ai1, Qiang Sun1   

  1. 1. Department of Second Surgery, Dushanzi Petrochemical Hospital, Xinjiang Uygur Autonomous Region, Karamay City 833600, China
  • Received:2016-08-26 Published:2016-12-01
  • Corresponding author: Lin Cai
  • About author:
    Corresponding author: Cai Lin, Email:
引用本文:

才林, 艾光禹, 孙强. 老年骨质疏松机制及股骨转子间骨折治疗的研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2016, 11(06): 469-472.

Lin Cai, Guangyu Ai, Qiang Sun. Research progress of the mechanism of senile osteoporosis and the teatment of intertrochanteric fracture[J/OL]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2016, 11(06): 469-472.

骨质疏松症是一种以脆性骨折为显著表现的全身性、代谢性骨骼系统疾病。其发病原因包括多种因素,根据目前的流行病学研究,骨质疏松及相关性骨折的发病率会继续增加。本文主要关注老年骨质疏松的机制、涉及相关基因、信号传递方面的基础研究及其继发股骨粗隆间骨折的临床治疗的进展。成骨细胞通过Wnt信号通路,促进成骨细胞活化。骨细胞通过产生前列腺素E2,促进细胞核因子κB受体激活蛋白(RANK)与细胞核因子κB受体激活蛋白配体(RANKL)结合,促进破骨细胞分化及其对骨的吸收。而成骨细胞则阻碍上述过程。丝裂原活化蛋白激酶信号通路中的ERK1/2通路、JNK通路、P38通路与骨质疏松的治疗有关。生长激素和胰岛素样生长因子通过JAK-STAT信号通路,保持成骨细胞和破骨细胞稳定维持骨量,若两者之间的关系破坏,则会出现骨质疏松。基于上述基础研究,临床上出现了更多的抗骨质疏松药物。在手术治疗方面,传统动力髋螺钉、解剖型钢板、Gamma钉、股骨近端髓内钉的地位继续下降,股骨近端防旋髓内钉(PFNA)及其改型PFNA-Ⅱ的发明和使用,坚持了科学的髓内固定,增加了对于股骨颈骨质的充填、提高了把持力、抗旋力和纵行加压,成为目前老年骨质疏松性粗隆间骨折临床治疗的首选。对于部分患者,髋关节置换也成为首次治疗或者补救性治疗的方法,虽然有较多缺点,但可提高手术疗效,早期下地。

Osteoporosis is a kind of brittle fracture as a significant manifestation of systemic, metabolic bone diseases. As a multifactorial diseases, the incidence of osteoporosis and related fractures will continue to increase, based on current epidemiological studies. This review focuses on progress of osteoporosis-related genes, signal transfer aspects of basic research and clinical treatment of secondary intertrochanteric fracture. Osteoblasts promote activation of osteoblast with Wnt pathway. By prostaglandin E2 (PGE2) bone cells promote the combination of receptor activator of NF-kB and receptor activator of nuclear factor κB ligand (RANK/RANKL), promoting osteoclast differentiation and bone absorption. Osteoblasts to the opposite. In the mitogen-activated protein kinase signaling pathway, ERK pathway, JNK pathway, P38 pathway and treatment of osteoporosis are closely linked. Through the JAK-STAT pathway, growth hormone and insulin-like growth factor-1 maintain the ratio osteoblasts and osteoclasts and then bone mass. Ratio imbalance leads osteoporosis. Based on the above basic research, more anti-osteoporosis drugs appear. Traditional surgical implants, such as dynamic hip screw, anatomical plate, gamma nail and proximal fermoral nail shrink, the use of PFNA/PFNA-Ⅱ gradually increases and becomes the first choice, which adheres to intramedullary fixation scientifically, compacts the femoral neck bone, increase the gripping, anti-rotation force and longitudinal stability.Although there are many shortcomings, hip replacement has become a remedial method effectively, songtimes the first options.

1
Johnell O, KanisJA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures[J]. Osteoporos Int, 2006, 17(12): 1726-1733.
2
Sasak N, Kusano E, Ando Y, et al. Glucocorticoid decreases circulating osteoprotegerin(OPG): possible mechanism for glueocortioid induced osteoperosis[J]. Nephrol Dial Transplant, 2001, 16(3): 479-482.
3
Karst M, Gorny G , Galvin RJ, et al. Roles of stromal cell RANKL, OPG, and M-CSF expression in biphasic TGF-beta regulation of osteoclast differentiation[J]. J Cell Physiol, 2004, 200(1): 99-106.
4
张波,耿彬.MAPK信号通路与骨质疏松关系的研究进展[J].中国矫形外科杂志,2014,22(23):2161-2165.
5
Moon SK, Cha BY, Kim CH. ERK1/2 mediates TNF-alpha-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-κB and AP-1: Involvement of the ras dependent pathway[J]. J Cell Physiol, 2004, 198(3): 417-427.
6
EFurqan M, Mukhi N, Lee B, et al. Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application[J]. Biomark Res, 2013, 15(1): 578-581.
7
Chen Y, Xia RG. Screening and functional microarray analysis of differentially expressed genes related to osteoporosis[J]. Genet Mol Res, 2014, 13(2): 3228-3236.
8
Arabi A, Zahed L, Mahfoud Z, et al. Vitamin D receptor gene polymorphisms modulate the skeletal response to vitamin D supplementation in healthy girls[J]. Bone, 2009, 45(6): 1091-1097.
9
Wu FY, Liu CS, Liao LN, et al. Vitamin D receptor variability and physical activity are jointly associated with low handgrip strength and osteoporosis in community-dwelling elderly people in Taiwan: the Taichung Community Health Study for Elders (TCHS-E)[J]. Osteoporos Int, 2014, 25(7): 1917-1929.
10
HG Bone, MCMcclung MR, Roux C, et al. Odanacatib, a cathepsin-K inhibitor for osteoporosis: a two-year study in postmenopausal women with low bone density[J]. J Bone Miner Res, 2009, 25(5): 937-947.
11
孟德军.抗旋转髓内钉和动力髋螺钉治疗老年股骨粗隆间不稳定骨折疗效比较[J].临床医学工程,2013,20(7):853-854.
12
肖海军,薛锋.PFN与PFNA内固定治疗老年骨质疏松性股骨粗隆间骨折的比较研究[J].中国骨与关节损伤杂志,2010,25(4):329-331.
13
Al-Yassari G, Langstaff RJ, Jones JW, et al. The AO/ASIF proximal femoral nail (PFN) for the treatment of unstable trochanteric femoral fracture[J]. Injury, , 2002, 33(5): 395-399.
14
Kim SY, Kim YG, Hwang JK. Cementless calcar-replacement hemiar -throplasty compared with intramedullary fixation of unstable-Intertrechantericfractures. A prospective, randomized study[J]. J Bone Joint Surg Am, 2005, 87(10): 2186-2192.
15
Haentjens P, Lamraski G, Boonen SP. Cost and consequences of hip fracture occurrence in old age: An economic perspective[J]. Disabil Rehabil, 2005, 27(18/19): 1129-1141.
16
刘永刚,李国有,高雁卿.人工股骨头置换治疗高龄股骨转子间骨折[J].临床医学,2007,27(10):10-11.
[1] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[2] 戴睿, 张亮, 陈浏阳, 张永博, 吴丕根, 孙华, 杨盛, 孟博. 肠道菌群与椎间盘退行性变相关性的研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 546-549.
[3] 易柏成, 李旭光, 王容容, 王新璇. 数字化3D打印导板应用于上前牙钙化根管治疗2例[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(06): 385-390.
[4] 严华悦, 刘子祥, 周少波. 磷酸烯醇式丙酮酸羧激酶-1在恶性肿瘤中的研究进展[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 452-456.
[5] 高俊颖, 张海洲, 区泓乐, 孙强. FOLFOX-HAIC 为基础的肝细胞癌辅助转化治疗的应用进展[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 457-463.
[6] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[7] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[8] 许月芳, 刘旺, 曾妙甜, 郭宇姝. 多粘菌素B和多粘菌素E治疗外科多重耐药菌感染临床疗效及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 700-703.
[9] 刘柏隆, 周祥福. 压力性尿失禁阶梯治疗的项目介绍[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 125-125.
[10] 刘柏隆. 女性压力性尿失禁阶梯治疗之手术治疗方案选择[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 126-126.
[11] 石海波, 赵旭东, 王聪, 曲巍. 气肿性肾盂肾炎、气肿性膀胱炎并脓毒性休克一例报道并文献复习[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 644-647.
[12] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
[13] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[14] 张平骥, 徐钰, 李天水, 庞文翼, 符师宁, 张梦圆. 重症患者镇静治疗现状及期望的调查研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 562-567.
[15] 王昌前, 林婷婷, 宁雨露, 王颖杰, 谭文勇. 光免疫治疗在肿瘤领域的临床应用新进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 575-583.
阅读次数
全文


摘要